Sonire Therapeutics Initiates First U.S. Clinical Trial of Ultrasound-Guided HIFU Therapy in Pancreatic Cancer May 26, 2026
NovAccel Secures Financing to Accelerate Medical Radioisotope Production for Next-Generation Cancer Therapy May 12, 2026
AIRNA Doses First Patient in Global Phase 1 Study of RNA Editing Candidate AIR-001 for AATD April 17, 2026
STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC-15 April 16, 2026
Sonire Therapeutics Closes $18 Million Series A to Advance HIFU Therapy for Pancreatic Cancer April 15, 2026
Fast Track Initiative Closes approximately 130M USD Fund IV to Advance Healthcare Innovation October 22, 2025
FTI Portfolio Company RegCell’s Scientific Founder, Professor Shimon Sakaguchi, Awarded the 2025 Nobel Prize in Physiology or Medicine October 8, 2025
Neusignal Therapeutics Completes First-in-Human Study of NTX-083 in Healthy Volunteers September 3, 2025
Astellas Exercises Option to License Small Molecules Discovered Through Joint Research on Novel target with Alivexis September 2, 2025
SONIRE Receives FDA IDE Approval for Ultrasound-Guided HIFU Device in Unresectable Pancreatic Cancer August 19, 2025
FTI Makes Follow-On Investment in Global Vascular’s Series B to Advance First-in-Human Trials of BioStealth™ Stent August 1, 2025
